TET2 loss enhances early response to inflammation in primitive and committed myeloid cells

Key Points

• Loss of TET2 leads to heightened inflammation and immune response in myeloid cells.
• The study shows that both primitive and committed myeloid cells exhibit increased responsiveness to inflammation.
• Analysis highlights the role of TET2 as a critical regulator in immune system function and cell differentiation.
• These findings may enable new therapeutic strategies targeting myeloid cell-mediated inflammation.